HIRU *****Update From: Investors Relations*****
For the one that missed it: We received notice of this (in a primer for a news release) from the company in a rough draft (read the response this going to explode, the word is just getting around).
05/13/2011
HIRU's Skull and Bones Ranking
In response to HIRU's recent ranking change to "Skull and Bones," (MMG) would like to update investors and followers:
HIRU has recently had a great deal of volume but no awareness of any kind was in force. So, why the huge volume, all of a sudden? We believe that this is due to the fact that HIRU has just been approved for a certain vaccine. This exciting event was posted on the China-based authority's (similar to a U.S.-based FDA for China) website. We believe that this news has been spread by Chinese investors and overflowed to English-Chinese speaking websites. We received notice of this (in a primer for a news release) from the company in a rough draft. We commenced our research and validation into this event for a North American or English-speaking news release.
We do have a China-based representative stationed in China and have requested that he investigate the validity of the claim and approval. We are advised that sufficient evidence exists to support that the event is a good and valid one. We recently commenced an OTCVerify report on HIRU which is in the process of being finalized.
This vaccine event is a game changer for HIRU. A decision was made to take a time out and evaluate the strategy for HIRU. The timeout was to address HIRU's next move. Was the company best served to do an audit, become a reporting issuer, move to a higher exchange, attempt to raise funds to start a mass distribution or various other alternatives?
The "Skull and Bones" rank came without warning and is unwarranted. This is a disingenuous "reward" for HIRU's hard work and efforts. The company is doing well, and has great assets, revenues and results from its work. The company has done nothing wrong! It appears that the only thing that aches OTC Markets is the fact that HIRU didn't pay the $3500 fee which allows them to post their financials. They have their own strategic reasons why they don't want to report how profitable they are. HIRU claims that it hurts future sales and competitors trash them, saying that they "overcharge".
MMG has kindly requested that OTC Markets revisit its down-ranking decision and advise the company accordingly. This is not the first China-based subsidiary that was knocked down to skull and bones for reaching successful milestones.
Its a head fake in this market!
It's all about the charts......& DD
